S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Will This Be the Worst U.S. Crisis Ever? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Will This Be the Worst U.S. Crisis Ever? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)

Encompass Health - EHC Stock Forecast, Price & News

$52.80
-0.11 (-0.21%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$52.69
$53.40
50-Day Range
$46.54
$65.59
52-Week Range
$44.33
$81.45
Volume
596,703 shs
Average Volume
987,475 shs
Market Capitalization
$5.27 billion
P/E Ratio
16.15
Dividend Yield
2.12%
Price Target
$73.60

Encompass Health MarketRank™ Forecast

Analyst Rating
Buy
3.11 Rating Score
Upside/​Downside
39.4% Upside
$73.60 Price Target
Short Interest
Healthy
2.34% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.68
Upright™ Environmental Score
News Sentiment
-0.58mentions of Encompass Health in the last 14 days
Based on 31 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
58.67%
From $2.25 to $3.57 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.44 out of 5 stars

Medical Sector

1st out of 1,293 stocks

Hospitals Industry

1st out of 4 stocks

EHC stock logo

About Encompass Health (NYSE:EHC) Stock

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Encompass Health Trading Down 0.2 %

Encompass Health stock traded down $0.11 during mid-day trading on Monday, hitting $52.80. The company's stock had a trading volume of 596,703 shares, compared to its average volume of 879,470. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.24 and a quick ratio of 1.24. The stock has a market cap of $5.27 billion, a price-to-earnings ratio of 16.29, a price-to-earnings-growth ratio of 3.21 and a beta of 0.91. The business has a 50 day moving average price of $53.89 and a 200-day moving average price of $62.73. Encompass Health has a 12 month low of $44.33 and a 12 month high of $81.45.

Encompass Health (NYSE:EHC - Get Rating) last released its quarterly earnings data on Monday, August 1st. The company reported $0.89 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.97 by ($0.08). Encompass Health had a net margin of 6.22% and a return on equity of 16.20%. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.34 billion. During the same quarter in the previous year, the firm posted $1.17 EPS. Encompass Health's revenue was up 3.3% compared to the same quarter last year. As a group, analysts forecast that Encompass Health will post 2.25 EPS for the current year.

Encompass Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date of this dividend is Friday, September 30th. Encompass Health's dividend payout ratio (DPR) is presently 34.25%.

Analyst Ratings Changes

EHC has been the subject of a number of recent analyst reports. Credit Suisse Group decreased their price target on Encompass Health from $83.00 to $82.00 and set an "outperform" rating for the company in a report on Friday, June 10th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Encompass Health from $80.00 to $62.00 in a research report on Wednesday, August 3rd. BMO Capital Markets dropped their price target on shares of Encompass Health from $83.00 to $65.00 and set an "outperform" rating on the stock in a research report on Thursday. Raymond James dropped their target price on shares of Encompass Health from $70.00 to $65.00 and set a "strong-buy" rating on the stock in a research report on Thursday. Finally, TheStreet cut shares of Encompass Health from a "b-" rating to a "c+" rating in a research report on Tuesday, June 28th. One investment analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $73.60.

Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Stock News Headlines

Encompass Health (NYSE:EHC) Downgraded by StockNews.com
Encompass Health (NYSE:EHC) Price Target Cut to $62.00
Analysts Set Encompass Health Co. (NYSE:EHC) PT at $79.56
Encompass Health (EHC) Set to Announce Earnings on Monday
5 Healthcare Stocks to Beat a Recession
EHC August 19th Options Begin Trading
See More Headlines
Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Company Calendar

Ex-Dividend for 7/20 Dividend
7/12/2022
Dividend Payable
7/20/2022
Last Earnings
8/01/2022
Today
8/09/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Hospitals
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
42192430
Employees
43,400
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$73.60
High Stock Price Forecast
$98.00
Low Stock Price Forecast
$62.00
Forecasted Upside/Downside
+39.4%
Consensus Rating
Buy
Rating Score (0-4)
3.11
Research Coverage
9 Analysts

Profitability

Net Income
$412.20 million
Pretax Margin
10.34%

Debt

Sales & Book Value

Annual Sales
$5.12 billion
Cash Flow
$6.90 per share
Book Value
$23.69 per share

Miscellaneous

Free Float
97,084,000
Market Cap
$5.27 billion
Optionable
Optionable
Beta
0.91

Social Links


Key Executives














EHC Stock - Frequently Asked Questions

Should I buy or sell Encompass Health stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EHC shares.
View EHC analyst ratings
or view top-rated stocks.

What is Encompass Health's stock price forecast for 2022?

9 brokers have issued 1-year target prices for Encompass Health's stock. Their EHC share price forecasts range from $62.00 to $98.00. On average, they expect the company's stock price to reach $73.60 in the next year. This suggests a possible upside of 39.4% from the stock's current price.
View analysts price targets for EHC
or view top-rated stocks among Wall Street analysts.

How has Encompass Health's stock performed in 2022?

Encompass Health's stock was trading at $65.26 at the beginning of 2022. Since then, EHC shares have decreased by 19.1% and is now trading at $52.80.
View the best growth stocks for 2022 here
.

Are investors shorting Encompass Health?

Encompass Health saw a decline in short interest in June. As of June 30th, there was short interest totaling 2,310,000 shares, a decline of 27.1% from the June 15th total of 3,170,000 shares. Based on an average daily volume of 812,700 shares, the days-to-cover ratio is currently 2.8 days. Approximately 2.4% of the shares of the stock are sold short.
View Encompass Health's Short Interest
.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our EHC earnings forecast
.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) issued its quarterly earnings data on Monday, August, 1st. The company reported $0.89 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.97 by $0.08. The company earned $1.33 billion during the quarter, compared to the consensus estimate of $1.34 billion. Encompass Health had a net margin of 6.22% and a trailing twelve-month return on equity of 16.20%. Encompass Health's quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.17 earnings per share.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Wednesday, July 20th. Stockholders of record on Monday, October 3rd will be given a dividend of $0.15 per share on Monday, October 17th. This represents a $0.60 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Friday, September 30th.
Read our dividend analysis for EHC
.

Is Encompass Health a good dividend stock?

Encompass Health (NYSE:EHC) pays an annual dividend of $1.12 per share and currently has a dividend yield of 2.12%. The dividend payout ratio is 34.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EHC will have a dividend payout ratio of 31.37% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EHC.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share guidance of $2.77-$2.91 for the period, compared to the consensus earnings per share estimate of $3.96. The company issued revenue guidance of $4.25 billion-$4.30 billion, compared to the consensus revenue estimate of $5.38 billion.

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health Chief Executive Officer Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among the company's employees.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Victory Capital Management Inc. (2.15%), Sumitomo Mitsui Trust Holdings Inc. (1.27%), Brown Advisory Inc. (1.19%), Reinhart Partners Inc. (0.92%), TimesSquare Capital Management LLC (0.88%) and Copeland Capital Management LLC (0.85%). Insiders that own company stock include Andrew L Price, Donald L Correll, Elissa Joy Charbonneau, Kevin J O'connor, Mark J Tarr and Terrance Williams.
View institutional ownership trends
.

How do I buy shares of Encompass Health?

Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $52.80.

How much money does Encompass Health make?

Encompass Health (NYSE:EHC) has a market capitalization of $5.27 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $3.27 on an earnings per share basis.

How many employees does Encompass Health have?

Encompass Health employs 43,400 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for the company is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at investorrelations@healthsouth.com, or via fax at 205-969-4719.

This page (NYSE:EHC) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.